Influence of Steroid Therapy on the Incidence of Pericarditis and Atrial Fibrillation After Percutaneous Epicardial Mapping and Ablation for Ventricular Tachycardia
Open Access
- 1 August 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 7 (4) , 671-676
Abstract
Background—: This study evaluates the influence of 3 therapeutic approaches on the incidence of pericarditis and atrial fibrillation (AF) after percutaneous epicardial mapping and ablation for ventricular tachycardia. Methods and Results—: Eighty-five consecutive procedures (2006–2011) were retrospectively reviewed. After the first 17 procedures (20.0%), no steroids were administered. For the subsequent 30 procedures (35.3%), systemic steroids were administered intravenously or orally, whereas the last 38 procedures (44.7%) were followed by intrapericardial steroid injection. Compared with no steroids, the incidence of pericarditic chest pain was significantly reduced by intrapericardial steroids (58.8% versus 21.1%; P =0.006) but not by intravenous or oral steroids (58.8% versus 43.4%; P =0.31). There was no significant difference in the incidence of pericarditic ECG with steroids (36.8%, 30.0%, and 41.2% for intrapericardial, intravenous or oral, and none, respectively). There was a nonsignificant reduced incidence of chest pain with ECG changes with steroids (13.2%, 10.0%, and 29.4% for intrapericardial, intravenous or oral, and none, respectively). Radiofrequency applications (65.9% of procedures) did not affect the incidence of pericarditic ECG changes, pericarditic chest pain, or pericarditis (all P >0.05). In 7 (8.3%) patients with no prior history of AF, AF was documented a median 36 hours after procedure. Patients with pericarditic ECG tended to be at greater risk of AF (16.7 versus 3.6%; P =0.091). Conclusions—: There is a high incidence of pericarditic chest pain and ECG changes after epicardial ventricular tachycardia mapping and ablation. Pericarditic chest pain is significantly decreased by intrapericardial steroids. Procedure-related AF is relatively frequent and tends to occur more commonly with pericarditic ECG changes.Keywords
This publication has 12 references indexed in Scilit:
- Epicardial Ablation for Ventricular TachycardiaCirculation: Arrhythmia and Electrophysiology, 2011
- Incidence, risk factors, and consequences of new-onset atrial fibrillation following epicardial ablation for ventricular tachycardiaEP Europace, 2011
- Epicardial Ventricular Tachycardia AblationJACC, 2010
- Ventricular Tachycardia AblationCirculation: Arrhythmia and Electrophysiology, 2008
- Experimental Efficacy of Pericardial Instillation of Anti‐inflammatory Agents during Percutaneous Epicardial Catheter Ablation to Prevent Postprocedure PericarditisJournal of Cardiovascular Electrophysiology, 2007
- Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone. The way to avoid side effects of systemic corticosteroid therapyEuropean Heart Journal, 2002
- Prevention of Postoperative Pericardial Adhesions Using Tissue-Protective SolutionsJournal of Surgical Research, 1997
- Intrapericardial triamcinolone hexacetonide in the treatment of intractable uremic pericarditis in a childPediatric Nephrology, 1988
- Iatrogenic Cushing's Syndrome After Intrapericardial Corticosteroid TherapyAnnals of Internal Medicine, 1981
- INTRAPERICARDIAL STEROIDS IN URÆMIC PERICARDITISThe Lancet, 1977